ASCO: Novartis To Face Challengers In Growing Radiopharmaceutical Space Scrip Pharma Intelligence 19:35 Thu, 11 Jun
Positive Del-brax biomarker data offers early support for Novartis’s Avidity bet Scrip Pharma Intelligence 14:19 Thu, 11 Jun
Novartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena 16:21 Thu, 11 Jun